{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:10:20Z","timestamp":1793725820391,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jacig.2025.100605","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:45:14Z","timestamp":1763444714000},"page":"100605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of prednisolone tapering and extended dupilumab dosing intervals on comorbid asthma in patients with chronic rhinosinusitis with nasal polyps"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1732-4856","authenticated-orcid":false,"given":"Shunsuke","family":"Minagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Matsuwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2025.100605_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/JAA.S81541","article-title":"United airway disease: current perspectives","volume":"9","author":"Giavina-Bianchi","year":"2016","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jacig.2025.100605_bib2","first-page":"27","article-title":"Regulation of interaction between the upper and lower airways in united airway disease","volume":"7","author":"Kanda","year":"2019","journal-title":"Med Sci"},{"key":"10.1016\/j.jacig.2025.100605_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaip.2019.07.016","article-title":"Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis","volume":"8","author":"Maspero","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10209","key":"10.1016\/j.jacig.2025.100605_bib4","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"issue":"suppl S29","key":"10.1016\/j.jacig.2025.100605_bib5","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jacig.2025.100605_bib6","article-title":"Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis","volume":"4","author":"Nakashima","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jacig.2025.100605_bib8","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/all.15796","article-title":"Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months","volume":"78","author":"van der Lans","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100605_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.21053\/ceo.2024.00233","article-title":"Therapeutic effectiveness of SNOT 22\u2013based interdose interval adjustment of dupilumab for chronic rhinosinusitis with nasal polyps","volume":"17","author":"Yoon","year":"2024","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.jacig.2025.100605_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4193\/Rhin17.156","article-title":"Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review","volume":"56","author":"Tsetsos","year":"2018","journal-title":"Rhinology"},{"issue":"3 pt 2","key":"10.1016\/j.jacig.2025.100605_bib11","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0194-5998(97)70005-6","article-title":"Staging for rhinosinusitis","volume":"117","author":"Lund","year":"1997","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jacig.2025.100605_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.anl.2010.05.013","article-title":"Clinical availability of a self-administered odor questionnaire for patients with olfactory disorders","volume":"38","author":"Takebayashi","year":"2011","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jacig.2025.100605_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.anl.2019.04.002","article-title":"Clinical practice guidelines for the management of olfactory dysfunction\u2014secondary publication","volume":"46","author":"Miwa","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jacig.2025.100605_bib14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (Feno) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2025.100605_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1165\/rcmb.2009-0425OC","article-title":"Selective nasal allergen provocation induces substance P\u2013mediated bronchial hyperresponsiveness","volume":"44","author":"Hens","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jacig.2025.100605_bib16","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1111\/all.14526","article-title":"Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation","volume":"75","author":"Hong","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2025.100605_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1096984","article-title":"A review of recent advances in exosomes and allergic rhinitis","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacig.2025.100605_bib18","first-page":"5921","article-title":"A disintegrin and metalloprotease 10\u2013containing exosomes derived from nasal polyps promote angiogenesis and vascular permeability","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jacig.2025.100605_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13698-x","article-title":"The upper-airway microbiota and loss of asthma control among asthmatic children","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacig.2025.100605_bib20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaip.2018.08.020","article-title":"Staphylococcus aureus nasal colonization and asthma in adults: systematic review and meta-analysis","volume":"7","author":"Kim","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2025.100605_bib21","article-title":"The effect of biologics in lung function and quality of life of patients with united airways disease: a systematic review","volume":"3","author":"Dom\u00ednguez-Ortega","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jacig.2025.100605_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.resinv.2025.02.003","article-title":"Eosinophilic chronic rhinosinusitis as a predictor of super-responder and clinical remission in patients with uncontrolled type 2\u2013high severe asthma treated with biologics","volume":"63","author":"Hamada","year":"2025","journal-title":"Respir Investig"},{"key":"10.1016\/j.jacig.2025.100605_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.rmed.2012.12.015","article-title":"Discordance between asthma control clinical, physiological and inflammatory parameters in mild asthma","volume":"107","author":"Boulay","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jacig.2025.100605_bib24","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"issue":"10039","key":"10.1016\/j.jacig.2025.100605_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2025.100605_bib26","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2025.100605_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S2213-2600(21)00322-2","article-title":"Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study","volume":"10","author":"Wechsler","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacig.2025.100605_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.anai.2021.01.012","article-title":"Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma","volume":"126","author":"Laidlaw","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2025.100605_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2147\/JAA.S357548","article-title":"Real-world effectiveness of dupilumab for patients with severe asthma: a retrospective study","volume":"15","author":"Numata","year":"2022","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jacig.2025.100605_bib30","first-page":"1811","volume":"Allergy 2025;80","author":"Portacci","year":"2025"},{"key":"10.1016\/j.jacig.2025.100605_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12931-023-02372-y","article-title":"Effectiveness and economic impact of dupilumab in asthma: a population-based cohort study","volume":"24","author":"Faverio","year":"2023","journal-title":"Respir Res"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325002061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325002061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:30:51Z","timestamp":1767861051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829325002061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2772829325002061"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100605","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of prednisolone tapering and extended dupilumab dosing intervals on comorbid asthma in patients with chronic rhinosinusitis with nasal polyps","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100605"}}